Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALRN | AMGN | BMY | VRTX | GILD |
| Company | Aileron Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 2.50 | 293.55 | 59.98 | 456.58 | 90.75 |
| High | 2.69 | 297.32 | 60.68 | 462.95 | 91.36 |
| Low | 2.45 | 293.50 | 58.63 | 455.83 | 89.50 |
| Last | 2.46 | 294.00 | 58.78 | 461.71 | 90.49 |
| Change | -0.01 | -0.53 | -0.09 | +10.74 | +0.30 |
| % Change | -0.40% | -0.18% | -0.15% | +2.38% | +0.33% |
| Volume | 83,900 | 4,695,600 | 14,116,649 | 2,168,100 | 10,753,999 |
| 20-Day Average Volume | 90,010 | 3,139,285 | 12,691,965 | 1,441,650 | 7,709,295 |
| Previous Close | 2.47 | 294.53 | 58.87 | 450.97 | 90.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.42 | 305.14 | 56.58 | 477.17 | 91.04 |
| 20-Day Raw Stochastic | 6.28% | 35.00% | 74.27% | 22.32% | 34.40% |
| 20-Day Relative Strength | 33.98% | 39.86% | 61.81% | 45.48% | 55.19% |
| Weighted Alpha | -47.18 | +2.07 | +26.74 | +22.42 | +24.57 |
| Today's Opinion | 56% Sell | 72% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 40% Sell | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Last Month's Opinion | 24% Buy | 8% Buy | 72% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.88% since 11/18/24 | +5.47% since 11/18/24 | +3.49% since 11/18/24 | -1.13% since 11/18/24 | +2.29% since 11/18/24 |
| Low | 2.33 on 11/22/24 | 275.56 on 11/19/24 | 56.10 on 11/19/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 3.11 on 11/20/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 463.90 on 11/19/24 | 91.36 on 11/25/24 |
| 1-Month | |||||
| %Chg | -33.78% since 10/25/24 | -7.25% since 10/25/24 | +13.21% since 10/25/24 | -3.35% since 10/25/24 | +1.67% since 10/25/24 |
| Low | 2.33 on 11/22/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 4.40 on 10/29/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +6.03% since 08/23/24 | -10.58% since 08/23/24 | +22.18% since 08/23/24 | -4.06% since 08/23/24 | +17.95% since 08/23/24 |
| Low | 2.26 on 08/29/24 | 275.56 on 11/19/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 76.42 on 08/26/24 |
| High | 4.40 on 10/29/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -29.91% since 05/24/24 | -3.87% since 05/24/24 | +42.53% since 05/24/24 | +1.04% since 05/24/24 | +37.77% since 05/24/24 |
| Low | 1.61 on 08/15/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 4.40 on 10/29/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 53,515 | 158,319,600 | 119,398,784 | 116,137,848 | 112,400,728 |
| Shares Outstanding, K | 21,666 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -15,730,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -5,850,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 2.35 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 11/14/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/15/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.08 | 49.77 | 0.00 | 20.26 |